What is the Future of Preclinical Trials in Cancer Research?
The future of preclinical trials in cancer research looks promising, with advancements in technology and methodologies driving progress. Innovations such as 3D cell cultures, organ-on-a-chip models, and CRISPR gene editing are enhancing the accuracy and relevance of preclinical studies. Additionally, the integration of artificial intelligence and machine learning is streamlining data analysis and accelerating the drug discovery process.
